Skip to content

Intellia Therapeutics NTLA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-636.6%+551pp-651.7%+271pp-832.2%+363pp-968.7%+126pp-1,187.4%-238pp
Net margin-597%+557pp-609.9%+287pp-774.9%+386pp-908.5%+154pp-1,154.1%-264pp
Returns
Return on equity-56.3%+1.6pp-53.5%+0.5pp-52.1%+0.1pp-57%-7.9pp-57.9%-14.3pp
Return on invested capital-62.8%-0.9pp-58.7%-0.4pp-60%-4.3pp-63.7%-11.3pp-61.9%-10.1pp
Efficiency
Asset turnover0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.0×
Liquidity
Current ratio6.1×+1.2×5.1×-0.7×6.2×-0.5×5.2×-2.0×4.9×-4.1×
Leverage
Debt-to-equity0.1×0.0×0.1×-0.1×0.1×0.0×0.1×0.0×0.2×0.0×
Per Share
Book value per share$5.24-30.5%$6.20-29.8%$6.79-28.7%$6.90-31.1%$7.54-30.5%
Valuation
Market capitalization$1.51B+106%$1.04B-12.3%$1.85B-7.0%$991.29M-53.6%$736.01M-70.4%
Price / sales22.9×+6.8×15.4×-5.1×32.2×-12.1×18.8×-25.9×16.2×-29.5×
Price / book2.4×+1.5×1.6×+0.2×2.5×+0.4×1.4×-0.8×0.9×-1.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Intellia Therapeutics's ratios come from?
Every ratio is computed from Intellia Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.